Michael G. Shlipak
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes 229
- Dialysis and Renal Disease Management 177
- Parathyroid Disorders and Treatments 54
- Cardiology and Cardiovascular Medicine top 0.05%
- Blood Pressure and Hypertension Studies 131
- Heart Failure Treatment and Management 45
- Cardiovascular Health and Disease Prevention 37
- Emergency Medicine top 0.05%
- HIV-related health complications and treatments 53
- Virology top 0.5%
- Geriatrics and Gerontology top 0.2%
-
- Renal and Vascular Pathologies 43
- Co-authors
- Linda F. FriedRonit KatzAnne B. NewmanJoachim H. IxDavid S. SiscovickMark J. SarnakBryan KestenbaumCatherine Stehman‐Breen
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Michael G. Shlipak
529 papers receiving 32.1k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Nephrology 15.2k
- Cardiology and Cardiovascular Medicine 10.7k
- Emergency Medicine 3.5k
- Virology 1.3k
- Geriatrics and Gerontology 765
Countries citing papers authored by Michael G. Shlipak
This map shows the geographic impact of Michael G. Shlipak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Shlipak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Shlipak more than expected).
Fields of papers citing papers by Michael G. Shlipak
This network shows the impact of papers produced by Michael G. Shlipak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Shlipak. The network helps show where Michael G. Shlipak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael G. Shlipak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 25 | |
| 14 | 2023 | 7 | |
| 15 | 2022 | 5 | |
| 16 | 2022 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2012 | 35 | |
| 19 | 2011 | 3 | |
| 20 | 2010 | 140 |
About Michael G. Shlipak
Michael G. Shlipak is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Emergency Medicine, having authored 544 papers that have together received 33.0k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (229 papers), Dialysis and Renal Disease Management (177 papers), Blood Pressure and Hypertension Studies (131 papers), Parathyroid Disorders and Treatments (54 papers), HIV-related health complications and treatments (53 papers), Heart Failure Treatment and Management (45 papers), Renal and Vascular Pathologies (43 papers) and Cardiovascular Health and Disease Prevention (37 papers). The work is most often cited by research in Nephrology (15.2k citations), Cardiology and Cardiovascular Medicine (10.7k citations) and Emergency Medicine (3.5k citations). Michael G. Shlipak has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Linda F. Fried, Ronit Katz, Anne B. Newman, Joachim H. Ix, David S. Siscovick, Mark J. Sarnak, Bryan Kestenbaum, Catherine Stehman‐Breen, Mary A. Whooley and Carmen A. Peralta. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.